Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Cancer Medicine|January 27, 2015
CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerationsLuis H CamachoExpert Opinion on Investigational Drugs|March 7, 2008
Novel therapies targeting the immune system: CTLA4 blockade with tremelimumab (CP-675,206), a fully human monoclonal antibodyLuis H CamachoClinical Journal of Oncology Nursing|November 8, 2003
Acute myeloid leukemia: a classification and treatment updateChristine Scura Iovino, Luis H CamachoLeukemia Research|August 22, 2006
Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndromeYin Gao, Luis H Camacho, Kapil MehtaCancer|August 24, 2005
Presentation and subsequent publication rates of phase I oncology clinical trialsLuis H Camacho, Jennifer Bacik, Alexander Cheung, et al.Oncology Letters|September 12, 2012
Chemokine expression in tumor-to-tumor metastasisJulio S N Peguero, Luis H Camacho, Bonnie Kemp, et al.Cancer Medicine|May 10, 2014
Biosimilars 101: considerations for U.S. oncologists in clinical practiceLuis H Camacho, Craig P Frost, Esteban Abella, et al.Cancer|September 1, 2005
A phase II trial of arsenic trioxide in patients with metastatic melanomaKevin B Kim, Agop Y Bedikian, Luis H Camacho, et al.Investigational New Drugs|October 21, 2006
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumorsLuis H Camacho, Jon Olson, William P Tong, et al.Investigational New Drugs|January 30, 2018
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumorsVicki L Keedy, Heinz-Josef Lenz, Leonard Saltz, et al.Pageof 4